Mark serves as Managing Director, Pyxis Advisors, where he consults on corporate strategy, new product commercialization, R&D prioritization, and corporate development projects in clinical diagnostics and medical devices. Most recently he served as the Vice President, Corporate Development at Oxford Immunotec, He previously served as Senior Vice President of Business Development at OraSure Technologies and held a number of commercial and strategic roles at Cytyc (Hologic) and LipoScience (LabCorp). Mark began his career as an Associate at McKinsey and Co. after attaining an MS in Bioengineering from Columbia University and a BS in Biology from Christian Brothers University.